NeuroX1

NeuroX1 is a computational neuroscience and drug discovery company building a platform to identify drivers of neurodegenerative and neurological diseases using proprietary generative AI algorithms. The platform employs deep reinforcement learning to generate novel drug compounds tailored to specific therapeutic parameters, targeting conditions such as Alzheimer's and ALS. Founded in 2021 by Maxwell Dordevic, Conner Myers, and Lucas Myers in Austin, Texas. The company raised $1.83M across multiple seed rounds from Drive Capital, Trousdale Ventures, and others. NeuroX1 participated in Techstars Knoxville.